TheraV
PrivateLast Round
Grant
Dec 16, 2021
Total Funding Raised
$167,000
Company Overview
TheraV is a therapeutic devices company that develops wearable products using vibration technology to help amputees manage phantom limb pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Health IoT
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TheraV Comps
Public and private peers based on sector, stage, and business model.
TheraV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 16, 2021 | ||||
| Accelerator | Sep 9, 2021 | ||||
| Grant | Jun 8, 2021 | ||||
| Grant | Mar 1, 2019 | ||||
| Grant | Jan 1, 2018 |
TheraV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delaware Division of Small Business | Grant |
| WomensNet | Grant |
| Startup Bucks | Accelerator |
| Horn Entrepreneurship | Grant |
| JPMorgan Chase Bank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Monthly visitors increased 444% MoM, reaching 1.8K.
- Dec 16, 2021
$100K grant received from Delaware Division of Small Business.
TheraV Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TheraV's valuation, stock price, and market status.
